Nocion Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Watertown, Massachusetts, focused on developing novel therapeutics to treat chronic cough and other conditions.
Subscribe to see Nocion Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nocion Therapeutics, Inc. is a therapeutics company headquartered in Watertown, United States. It has raised at least $107M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round, Series B Extension, raised $23M in January 2026. Xcout tracks 18 named people at Nocion Therapeutics, Inc., including Richard P. Batycky (CEO).
As of 16 November 2026. Source: Xcout Intel.
12 more named people on record for Nocion Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $107M raised across the 5 rounds on record (4 with a disclosed amount). The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B Extension | $23M | 1 named | |
| Series B | $62M | 7 named | |
| SEC Form D filing | $7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 10 named investors across 4 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Nocion Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Sionna Therapeutics is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, focused on developing treatments for cystic fibrosis.
Cardurion Pharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in Burlington, Massachusetts, focused on discovering and developing novel therapeutics for cardiovascular diseases.
Nido Biosciences, Inc. is a clinical-stage holding and biotechnology company headquartered in Watertown, Massachusetts. The company focuses on discovering and advancing treatments for debilitating neurological diseases, including the development of targeted drugs.
Nexo Therapeutics, Inc. is a therapeutics company focused on targeting challenging and transient protein pockets, with its corporate address located in Watertown, Massachusetts.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel non-opioid therapeutics for the treatment of chronic pain and painful conditions.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Nocion Therapeutics, Inc.? Suggest a correction · Work at Nocion Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.